Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jan 30;10(1):e0113961.
doi: 10.1371/journal.pone.0113961. eCollection 2015.

Baseline magnetic resonance imaging of the optic nerve provides limited predictive information on short-term recovery after acute optic neuritis

Affiliations

Baseline magnetic resonance imaging of the optic nerve provides limited predictive information on short-term recovery after acute optic neuritis

Sebastian Berg et al. PLoS One. .

Abstract

Background: In acute optic neuritis, magnetic resonance imaging (MRI) may help to confirm the diagnosis as well as to exclude alternative diagnoses. Yet, little is known on the value of optic nerve imaging for predicting clinical symptoms or therapeutic outcome.

Purpose: To evaluate the benefit of optic nerve MRI for predicting response to appropriate therapy and recovery of visual acuity.

Methods: Clinical data as well as visual evoked potentials (VEP) and MRI results of 104 patients, who were treated at the Department of Neurology with clinically definite optic neuritis between December 2010 and September 2012 were retrospectively reviewed including a follow up within 14 days.

Results: Both length of the Gd enhancing lesion (r = -0.38; p = 0.001) and the T2 lesion (r = -0.25; p = 0.03) of the optic nerve in acute optic neuritis showed a medium correlation with visual acuity after treatment. Although visual acuity pre-treatment was little but nonsignificantly lower if Gd enhancement of the optic nerve was detected via orbital MRI, improvement of visual acuity after adequate therapy was significantly better (0.40 vs. 0.24; p = 0.04). Intraorbitally located Gd enhancing lesions were associated with worse visual improvement compared to canalicular, intracranial and chiasmal lesions (0.35 vs. 0.54; p = 0.02).

Conclusion: Orbital MRI is a broadly available, valuable tool for predicting the improvement of visual function. While the accurate individual prediction of long-term outcomes after appropriate therapy still remains difficult, lesion length of Gd enhancement and T2 lesion contribute to its prediction and a better short-term visual outcome may be associated with detection and localization of Gd enhancement along the optic nerve.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: Dr. Sebastian Berg reports personal fees from Biogen Idec, personal fees from Novartis, outside the submitted work. Dr. Iris Kaschka has nothing to disclose. Dr. Kathrin Utz reports grants from Novartis, grants from Biogen Idec, outside the submitted work. Dr. Konstantin Huhn reports personal fees from Biogen Idec, personal fees from Novartis, personal fees from Merck Serono, outside the submitted work. Dr. Alexandra Lämmer has nothing to disclose. Dr. Robert Lämmer has nothing to disclose. Dr. Anne Waschbisch reports grants, personal fees and non-financial support from Biogen Idec GmbH, grants, personal fees and non-financial support from Merck Serono GmbH, personal fees and non-financial support from Teva/Sanofi Aventis, grants and personal fees from Bayer Schering, outside the submitted work. Dr. Stephan Kloska has nothing to disclose. Dr. De-Hyung Lee has nothing to disclose. Dr. Arnd Dörfler has nothing to disclose. Dr. Ralf Linker received honoraria and travel support from Bayer, BiogenIdec, Genzyme, Merck Serono, Novartis, TEVA Pharma and Research Support from BiogenIdec, Merck Serono and Genzyme, outside the submitted work. The authors confirm that co-author Ralf Linker is a PLOS ONE Editorial Board member. This does not alter the authors’ adherence to PLOS ONE Editorial policies and criteria.

Figures

Figure 1
Figure 1. Gd enhancement and T2 lesion of the right optic nerve.
Optic nerve MR imaging of a representative patient with ON. (A) Coronar fat-saturated T1-weighted MRI sequences of the intraorbital and (B) canalicular part of the optic nerve after application of 0.1mmol/kg gadolinium. The arrows highlight the Gd enhanced right optic nerve. (C) Signalalteration of the intraorbital and (D) canalicular part of the optic nerve in coronar fat-saturated T2 turbo spin-echo MRI sequences. The arrows highlight the hypertense T2 lesion of the right optic nerve.
Figure 2
Figure 2. Patients with Gd enhancement of the optic nerve show significant higher visual improvement.
(A) Mean improvement of visual acuity of patients with or without either T2 lesion or Gd enhancement of the optic nerve in orbital MRI. Error bars indicate standard error of the mean. * indicates significant difference with p = 0.04 as determined via Mann-Whitney rank sum test. Improvement of visual acuity was defined as difference between visual acuity before and after adequate treatment. (B) Mean visual acuity of patients with or without T2 lesion or Gd enhancement of the optic nerve in orbital MRI before and after adequate therapy. Error bars indicate standard error of the mean. No significant differences were found between the single groups.

Similar articles

Cited by

References

    1. Schinzel J, Schwarzlose L, Dietze H, Bartusch K, Weiss S, et al. (2012) Efficacy of vision restoration therapy after optic neuritis (VISION study): study protocol for a randomized controlled trial. Trials 13: 94 10.1186/1745-6215-13-94 - DOI - PMC - PubMed
    1. Hoorbakht H, Bagherkashi F (2012) Optic neuritis, its differential diagnosis and management. Open Ophthalmol J 6: 65–72. 10.2174/1874364101206010065 - DOI - PMC - PubMed
    1. Kale N (2012) Management of optic neuritis as a clinically first event of multiple sclerosis. Curr Opin Ophthalmol 23: 472–476. 10.1097/ICU.0b013e328358b202 - DOI - PubMed
    1. Dooley MC, Foroozan R (2010) Optic neuritis. J Ophthalmic Vis Res 5: 182–187. - PMC - PubMed
    1. Balcer LJ (2006) Clinical practice. Optic neuritis. N Engl J Med 354: 1273–1280. 10.1056/NEJMcp053247 - DOI - PubMed